Insight Molecular Diagnostics

OCX · NASDAQ

$3.03+$0.14 (+4.84%)TodayMarket closed ·
Prev close $2.89

Revenue by product and region

Fiscal year ended Dec 31, 2025: $4.05M total revenue

By product

  • Laboratory Services [Member]$4.03M99.4%
  • Kitted Products [Member]$24.00K0.6%

Suppliers and customers

Price correlation is over one year: 1 means the stocks move together, -1 opposite

Insight Molecular Diagnostics suppliers and customers
CompanyRelationshipCorrelation
Burning Rock Biotech ADR BNRSupplier and customer0.98
Thermo Fisher Scientific TMOSupplier and customer-0.37
United StatesCustomer—
University of California, San FranciscoSupplier and customer—

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.